BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer

Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer

(2016) Shoichiro Mukai et al.   ANNALS OF SURGICAL ONCOLOGY

Global trends in incidence and mortality of nasopharyngeal carcinoma

(2016) Ling-Ling Tang et al.   CANCER LETTERS

Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells

(2016) Wei Shi et al.   JOURNAL OF PATHOLOGY

Cisplatin resistance and opportunities for precision medicine

(2016) Lauren Amable   PHARMACOLOGICAL RESEARCH

Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1

(2016) L Qiu et al.   Cell Death & Disease

Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study

(2015) Sum-Fu Chiang et al.   DISEASE MARKERS

MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

(2015) L. R. Kong et al.   MOLECULAR CANCER THERAPEUTICS

Intrinsic host restrictions to HIV-1 and mechanisms of viral escape

(2015) Viviana Simon et al.   NATURE IMMUNOLOGY

Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials

(2015) Cheng-run Du et al.   Radiation Oncology

High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy

(2015) Xiang Fu et al.   Oncotarget

ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib

(2015) Jiani Liu et al.   Oncotarget

CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy

(2014) L. Ding et al.   CANCER RESEARCH

Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer

(2014) Ku-Hao Fang et al.   LARYNGOSCOPE

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer

(2014) Yi Zhou et al.   Molecular Cancer

Multicenter Randomized Phase 2 Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma

(2014) Wen Ye et al.   MOLECULAR THERAPY

Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a

(2013) Ji-Ye Yin et al.   CARCINOGENESIS

Enhancer of Zeste Homolog 2 Is a Negative Regulator of Mitochondria-Mediated Innate Immune Responses

(2013) S. Chen et al.   JOURNAL OF IMMUNOLOGY

Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells

(2013) R.-Y. Liu et al.   MOLECULAR CANCER THERAPEUTICS

Innate Sensing of HIV-1 Assembly by Tetherin Induces NFκB-Dependent Proinflammatory Responses

(2012) Rui Pedro Galão et al.   Cell Host & Microbe

Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma

(2012) Ran-yi Liu et al.   Journal of Translational Medicine

Stimulation of NF- B Activity by the HIV Restriction Factor BST2

(2012) A. Tokarev et al.   JOURNAL OF VIROLOGY

Identification of Alternatively Translated Tetherin Isoforms with Differing Antiviral and Signaling Activities

(2012) Luis J. Cocka et al.   PLoS Pathogens

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

(2011) Lei Chen et al.   LANCET ONCOLOGY

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma

(2011) R-Y Liu et al.   ONCOGENE

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance

(2011) K. Tanaka et al.   Cancer Discovery

Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes

(2010) Saeed Ahmad   CHEMISTRY & BIODIVERSITY

Genistein Induces Growth Inhibition and G2/M Arrest in Nasopharyngeal Carcinoma Cells

(2010) Hongyu Han et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

The Great Escape: Viral Strategies to Counter BST-2/Tetherin

(2010) Janet L. Douglas et al.   PLoS Pathogens

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis

(2009) Dongqing Cai et al.   BMC CANCER

Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-κB pathway

(2009) Zhi-Hua Li et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody

(2008) Wei Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Inhibition of NF-κB in fusogenic membrane glycoprotein causing HL-60 cell death: Implications for acute myeloid leukemia

(2008) Li Tan et al.   CANCER LETTERS

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

(2008) Stuart J. D. Neil et al.   NATURE